Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
GLAXO
₹2,930
₹2865.40
₹2955.90
₹2088.10
₹3054.90
Markets Today
Historical Performance
As of 25-08-2026 00:02, GlaxoSmithKline Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-2902.20 (-100.00%) from the previous close of ₹2902.2. The stock opened at ₹2875.1 and traded between ₹2865.4 and ₹2955.9, with a total traded volume of 80140 shares. The company has a market capitalization of ₹49165 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3054.9 and ₹2088.1, respectively.
GlaxoSmithKline Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 46, EPS of ₹61.15, and book value of ₹19.60. Profitability indicators show ROE of 45.68% along with a dividend yield of 2%. GlaxoSmithKline Pharmaceuticals Ltd. has reported revenue of ₹3954.94 Cr and net profit of ₹1068.15 Cr.
GlaxoSmithKline Pharmaceuticals Ltd. technical indicators include Day RSI at 68.85, Day MFI at 90.8, Day ADX at 39.43. Additional indicators include Commodity Channel Index (CCI) at 157.5 and Williams %R at -28.28. Momentum indicators show Day MACD at 113.99, Day MACD Signal Line at 83.75, DayATR at 85.81. Rate of Change indicators for GlaxoSmithKline Pharmaceuticals Ltd. include ROC125 at 11.47 and ROC21 at 16.32.
Exponential moving averages include EMA5 at ₹2894.1, EMA10 at ₹2812.7, EMA12 at ₹2788.3, EMA20 at ₹2715.1, EMA26 at ₹2674.3, EMA50 at ₹2571.8, EMA100 at ₹2502.4, EMA200 at ₹2510.2. Simple moving averages include SMA5 at ₹2902.9, SMA10 at ₹2769.4, SMA20 at ₹2691.4, SMA30 at ₹2623.6, SMA50 at ₹2512.3, SMA100 at ₹2427.7, SMA150 at ₹2440.9, SMA200 at ₹2459.9.
Support levels for GlaxoSmithKline are placed at First Support ₹2858.33, Second Support ₹2814.47, Third Support ₹2748.93. Resistance levels are seen at First Resistance ₹2967.73, Second Resistance ₹3033.27, Third Resistance ₹3077.13. GlaxoSmithKline Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 4.79%, DII holding at 0%, public holding at 12.42%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 924.42 | 989.15 | 1,022.59 | 973.63 | 804.83 |
| Operating Expense | 631.26 | 641.96 | 655.01 | 638.95 | 554.08 |
| Operating Profit | 293.16 | 347.19 | 367.58 | 334.68 | 250.75 |
| Depreciation | 15.84 | 13.17 | 20.32 | 17.43 | 15.52 |
| Interest | 0.97 | 0.61 | 1.19 | 0.51 | 0.42 |
| Tax | 84.65 | 94.18 | 100.71 | 95.65 | 73.87 |
| Net Profit | 253.33 | 274.94 | 277.18 | 255 | 204.70 |
₹2930.00
↗ Bullish Moving Average
15
↘ Bearish Moving Average
1
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 4.5 | 4.9 | 5 | 4.6 | 4.6 | 4.8 |
| DII | 7.8 | 7.7 | 8 | 7.7 | 7.7 | 7.8 |
| Public | 12.7 | 12.4 | 12 | 12.7 | 12.7 | 12.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 39.55 K | 93.13 K | 42.47% |
| Week | 2.11 L | 4.95 L | 42.62% |
| 1 Month | 79.41 K | 1.67 L | 47.59% |
| 6 Month | 66.33 K | 1.14 L | 58.29% |
Companies with no Debt
Benjamin Graham Value Screen
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
Dividend yield greater than sector dividend yield
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 May, 2026 | 57 | FINAL | 29 May, 2026 | Equity Share |
| 30 May, 2025 | 42 | FINAL | 30 May, 2025 | Equity Share |
| 07 Nov, 2024 | 12 | INTERIM | 07 Nov, 2024 | Equity Share |
| 31 May, 2024 | 32 | FINAL | 31 May, 2024 | Equity Share |
| 30 Jun, 2023 | 32 | FINAL | 30 Jun, 2023 | Equity Share |
| 07 Jul, 2022 | 60 | SPECIAL | 08 Jul, 2022 | Equity Share |
| 07 Jul, 2022 | 30 | FINAL | 08 Jul, 2022 | Equity Share |
| 19 Jul, 2021 | 30 | FINAL | 20 Jul, 2021 | Equity Share |
| 17 Jul, 2020 | 20 | SPECIAL | 20 Jul, 2020 | Equity Share |
| 17 Jul, 2020 | 20 | FINAL | 20 Jul, 2020 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,766 | ₹883.60 | ₹1,436.80 | ₹1,862 | ₹2,374.50 | ₹212.43 |
| % Change | 2.39% | 1.39% | -1.41% | -0.05% | -0.40% | -0.58% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 99.10 | 85.20 | 85.50 | 34.90 | 48.20 | -90.70 |
| 1 Year Return | 255.61 | 5.9 | 57.4 | 24.77 | -8.55 | 10.85 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 3171.00
+0.06%
Gland Pharma Ltd.
₹ 2811.90
-0.26%
Laurus Labs Ltd.
₹ 1801.00
-0.06%
Alkem Laboratories Ltd.
₹ 5350.00
-0.93%
Biocon Ltd.
₹ 409.40
-1.48%
Divi's Laboratories Ltd.
₹ 8496.00
-1.17%
Granules India Ltd.
₹ 857.00
-0.13%
Ajanta Pharma Ltd.
₹ 3581.00
-1.62%
Zydus Lifesciences Ltd.
₹ 1103.80
-1.45%
Glenmark Pharmaceuticals Ltd.
₹ 2390.70
+3.14%
Wockhardt Ltd.
₹ 1902.00
+0.83%
Aurobindo Pharma Ltd.
₹ 1608.00
-0.82%
Sun Pharmaceutical Industries Ltd.
₹ 1910.00
+0.40%
Neuland Laboratories Ltd.
₹ 22901.00
-1.72%
Ipca Laboratories Ltd.
₹ 1921.00
+0.51%
Pfizer Ltd.
₹ 4886.00
-1.85%
Abbott India Ltd.
₹ 26450.00
+0.84%
Torrent Pharmaceuticals Ltd.
₹ 4886.50
-0.20%
Lupin Ltd.
₹ 2188.00
-0.63%
Dr. Reddy's Laboratories Ltd.
₹ 1190.00
+1.30%
Cipla Ltd.
₹ 1437.90
+0.40%
By signing up I certify terms, conditions & privacy policy